Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 26, 2017

DrugPatentWatch Database Preview

Meclizine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for meclizine hydrochloride and what is the scope of patent protection?

Meclizine hydrochloride
is the generic ingredient in two branded drugs marketed by Superpharm, Vangard, Casper Pharma Llc, Kv Pharm, Par Pharm, Pliva, Mylan Pharms Inc, Watson Labs, Sandoz, Amneal Pharms, Abc Holding, UDL, Ani Pharms Inc, Jubilant Cadista, Bundy, Ivax Sub Teva Pharms, Rising Pharms Inc, Anabolic, Nexgen Pharma Inc, and Epic Pharma Llc, and is included in thirty-five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for meclizine hydrochloride. Forty-one suppliers are listed for this compound.

Summary for Generic Name: meclizine hydrochloride

Drug Master File Entries: see list17
Suppliers / Packagers: see list41
Bulk Api Vendors: see list101
Clinical Trials: see list991
Patent Applications: see list6,582
Therapeutic Class:Antiemetics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:meclizine hydrochloride at DailyMed

Pharmacology for Ingredient: meclizine hydrochloride

Drug ClassAntiemetic
Physiological EffectEmesis Suppression
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
meclizine hydrochloride
TABLET;ORAL085195-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Amneal Pharms
meclizine hydrochloride
TABLET;ORAL201451-003Feb 23, 2011DISCNNoNo► Subscribe► Subscribe
Watson Labs
meclizine hydrochloride
TABLET;ORAL085740-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
meclizine hydrochloride
TABLET, CHEWABLE;ORAL088733-001Dec 11, 1985DISCNNoNo► Subscribe► Subscribe
meclizine hydrochloride
TABLET;ORAL084382-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Formulary management
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus